Kaida A, Kabakyenga JK, Bwana M, Bajunirwe F, Muyindike WR, et al.
2019-08-15 • Journal of Acquired Immune Deficiency Syndromes (1999)
2019-08-15 • Journal of Acquired Immune Deficiency Syndromes (1999)
Many men with HIV express fertility intentions and nearly half have HIV-uninfected sexual partners. We measured partner pregnancy among a cohort of men accessing antiretroviral therapy (...
O'Brien DP, Ford NP, Djirmay AG, Calmy A, Victoria M, et al.
2019-01-25 • Journal of Acquired Immune Deficiency Syndromes (1999)
2019-01-25 • Journal of Acquired Immune Deficiency Syndromes (1999)
Evidence suggests that there are important interactions between HIV and Female Genital Schistosomiasis (FGS) that may have significant effects on individual and population health. Howeve...
Castillo-Mancilla JR, Morrow M, Boum Y II, Byakwaga H, Haberer JE, et al.
2018-01-16 • Journal of Acquired Immune Deficiency Syndromes (1999)
2018-01-16 • Journal of Acquired Immune Deficiency Syndromes (1999)
Residual systemic inflammation persists despite suppressive antiretroviral therapy (ART) and is associated with non-AIDS clinical outcomes. We aimed to evaluate the association between A...
Lawn SD, Campbell L, Kaplan R, Boulle AM, Cornell M, et al.
2011-06-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2011-06-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
We studied the time interval between starting tuberculosis treatment and commencing antiretroviral treatment (ART) in HIV-infected patients (n = 1433; median CD4 count 71 cells per micro...
Hoffman CJ, Schomaker M, Fox MP, Mutevedzi, Giddy J, et al.
2013-01-22 • Journal of Acquired Immune Deficiency Syndromes (1999)
2013-01-22 • Journal of Acquired Immune Deficiency Syndromes (1999)
In many resource-limited settings monitoring of combination antiretroviral therapy (cART) is based on the current CD4 count, with limited access to HIV RNA tests or laboratory diagnostic...
Singh A, Sunpath H, Green TN, Padayachi N, Hiramen K, et al.
2011-11-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2011-11-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND Drug resistance poses a significant challenge for the successful application of highly active antiretroviral therapy (HAART) globally. Furthermore, emergence of HIV-1 isol...
Fenner L, Brinkhof MW, Keiser O, Weigel R, Cornell M, et al.
2010-08-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2010-08-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND: Many HIV-infected children in Southern Africa have been started on antiretroviral therapy (ART), but loss to follow up (LTFU) can be substantial. We analyzed mortality in chi...
Tassie JM, Grabar S, Lancar R, Deloumeaux J, Bentata M, et al.
2002-05-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2002-05-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
To estimate the change in AIDS incubation time during three periods characterized by different availability of antiretroviral treatments, data from the French Hospital Database on HIV of...
Kerschberger B, Ntshalintshali N, Mpala Q, Diaz Uribe PA, Maphalala G, et al.
2019-09-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2019-09-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND To assess the performance and suitability of dried blood spot (DBS) sampling using filter paper to collect blood for viral load (VL) quantification under routine condition...
et al.
2021-04-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2021-04-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
Huerga H, Rucker SCM, Bastard M, Dimba A, Kamba C, et al.
2020-01-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2020-01-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
Background: Current eligibility criteria for urine lateral-flow-lipoarabinomannan assay (LF-LAM) in ambulatory, HIV-positive patients rely on the CD4 count. We investigated the diagnosti...
Pannus P, Fajardo E, Metcalf CJ, Coulborn R M, Duran LT, et al.
2013-07-25 • Journal of Acquired Immune Deficiency Syndromes (1999)
2013-07-25 • Journal of Acquired Immune Deficiency Syndromes (1999)
: Rollout of routine HIV-1 viral load monitoring is hampered by high costs and logistical difficulties associated with sample collection and transport. New strategies are needed to overc...
Kaida A, Matthews LT, Ashaba S, Tsai AC, Kanters S, et al.
2014-12-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2014-12-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
Among HIV-infected women, perinatal depression compromises clinical, maternal, and child health outcomes. Antiretroviral therapy (ART) is associated with lower depression symptom severit...
Muiru AN, Bibangambah P, Hemphill LC, Sentongo R, Kim JH, et al.
2018-04-11 • Journal of Acquired Immune Deficiency Syndromes (1999)
2018-04-11 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND The utility and validity of cardiovascular diseases (CVD) risk scores are not well studied in sub-Saharan Africa. We compared and correlated CVD risk scores with carotid i...
Mueller YK,
Ferlazzo G,
et al.
2015-11-11 • Journal of Acquired Immune Deficiency Syndromes (1999)
2015-11-11 • Journal of Acquired Immune Deficiency Syndromes (1999)
Hoffman CJ,
et al.
2015-07-07 • Journal of Acquired Immune Deficiency Syndromes (1999)
2015-07-07 • Journal of Acquired Immune Deficiency Syndromes (1999)
Greig J, O'Brien DP, Ford NP, Spelman T, Sabapathy K, et al.
2011-11-30 • Journal of Acquired Immune Deficiency Syndromes (1999)
2011-11-30 • Journal of Acquired Immune Deficiency Syndromes (1999)
Vertical HIV programs have achieved good results but may not be feasible or appropriate in many resource-limited settings. Médecins sans Frontières has treated HIV in vertical programs s...
Huerga H, van Cutsem G, Ben Farhat J, Reid M, Bouhenia M, et al.
2016-12-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2016-12-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
Identifying gaps in HIV testing and treatment is essential to design specific strategies targeting those not accessing HIV services. We assessed the prevalence and factors associated wit...
